Aside

Contact info

For more information, please contact me via email.

skills

-Highly skilled in performing and establishing in vitro and in vivo experiments for studying cancer stemness and metastasis in ovarian cancer and lung cancer.

-Extensive experience in studying the regulation of microRNAs and long non-coding RNAs in ovarian cancer and lung cancer.

-Experienced in establishment of orthotopic mouse model for ovarian cancer (intrabursal injection).

-Experienced in R for studying the clinical relevance in TCGA datasets.

Main

Chia-Hao Tung

Postdoctoral fellow at Institute of Clinical Medicine,
National Cheng Kung University.

Research Interests:

  • Translational medicine
  • Cancer biology
  • Bioinformatics

Employment

Postdoctoral fellow

National Cheng Kung University

Tainan, Taiwan

2020 - Present

  • Identification and investigation of long non-coding RNAs in regulating the stemness properties of lung cancer
  • Study of the clinical assciation between long non-coding RNAs and cancer stemness pathways in lung cancer using bioinformatic analysis

Education

National Cheng Kung University

Ph.D. in Basic Medical Sciences

Tainan, Taiwan

2012 - 2019

National Cheng Kung University

M.S. in Clinical Medicine

Tainan, Taiwan

2009 - 2011

China Medical University, CMU

B.S. in Biotechnology

Taichung, Taiwan

2005 - 2009

honors and awards

Honorary Membership of The Phi Tau Phi Scholastic
Honor Society of the Republic of China

The Phi Tau Phi Scholastic Honor Society of
the Republic of China

Tainan, Taiwan

2020

AACR-Aflac, Inc. Scholar-In-Training Award

American Association for Cancer Research

Shanghai, China

2017

The Merit Award, oral presentation

Taiwan Genomics and Genetics Society

Nantou, Taiwan

2016

The Merit Award, poster presentation

Taiwan Genomics and Genetics Society

Nantou, Taiwan

2014

Publications

DNA methylation maintains the CLDN1-EPHB6-SLUG axis to enhance chemotherapeutic efficacy and inhibit lung cancer progression

Theranostics. 2020, 10 (19), 8903-8923

N/A

2020

  • Wu JE, Wu YY, Tung CH, Tsai YT, Chen HY, Chen YL*, Hong TM*.

MicroRNA-150-5p promotes cell motility by inhibiting c-Myb-mediated Slug suppression and is a prognostic biomarker for recurrent ovarian cancer

Oncogene. 2020, 39 (4), 862-876.

N/A

  • Tung CH, Kuo LW, Huang MF, Wu YY, Tsai YT, Wu JE, Hsu KF, Chen YL*, Hong TM*.

A DNA Aptamer Targeting Galectin-1 as a Novel Immunotherapeutic Strategy for Lung Cancer

Molecular Therapy - Nucleic Acids. 2019, 18, P991-998.

N/A

2019

  • Tsai YT, Liang CH, Yu JH, Huang KC, Tung CH, Wu JE, Wu YY, Chang CH, Hong TM*, Chen YL*.

CASZ1 is a novel promoter of metastasis in ovarian cancer

American Journal of Cancer Research. 2016, 6 (6), 1253-1270.

N/A

2016

  • Wu YY, Chang CL, Chuang YJ, Wu JE, Tung CH, Chen YC, Chen YL, Hong TM, Hsu KF.

This resume was made with the R package pagedown.

Last updated on 2020-08-04.